The FDA has updated its list of blood pressure medications that are being recalled after traces of a cancer-causing ingredient were found in several batches.
The agency last month said it was recalling valsartan tablets made in China after tests showed some contained Nitrosodimethylamine, or NDMA, a probable carcinogen.
